ARWR
$64.19-0.93%
as of close, Oct 2, 2026
☾ AH $64.19 -0.93%
Arrowhead Pharmaceuticals Inc.Stock · Health CareNasdaq Composite 0.02%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.01%
Arrowhead Pharmaceuticals Inc. returns by year
As of market close, Oct 2, 2026
Arrowhead Pharmaceuticals Inc. returns by year (1994–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $66.39 | $64.19 | 0.0% | -3.3% | |
| 2025 | $18.80 | $66.39 | 0.0% | +253.1% | |
| 2024 | $30.60 | $18.80 | 0.0% | -38.6% | |
| 2023 | $40.56 | $30.60 | 0.0% | -24.6% | |
| 2022 | $66.30 | $40.56 | 0.0% | -38.8% | |
| 2021 | $76.73 | $66.30 | 0.0% | -13.6% | |
| 2020 | $63.43 | $76.73 | 0.0% | +21.0% | |
| 2019 | $12.42 | $63.43 | 0.0% | +410.7% | |
| 2018 | $3.68 | $12.42 | 0.0% | +237.5% | |
| 2017 | $1.55 | $3.68 | 0.0% | +137.4% | |
| 2016 | $6.15 | $1.55 | 0.0% | -74.8% | |
| 2015 | $7.38 | $6.15 | 0.0% | -16.7% | |
| 2014 | $10.85 | $7.38 | 0.0% | -32.0% | |
| 2013 | $2.14 | $10.85 | 0.0% | +407.0% | |
| 2012 | $4.19 | $2.14 | 0.0% | -48.9% | |
| 2011 | $8.95 | $4.19 | 0.0% | -53.2% | |
| 2010 | $5.30 | $8.95 | 0.0% | +68.9% | |
| 2009 | $9.20 | $5.30 | 0.0% | -42.4% | |
| 2008 | $37.80 | $9.20 | 0.0% | -75.7% | |
| 2007 | $43.80 | $37.80 | 0.0% | -13.7% | |
| 2006 | $42.50 | $43.80 | 0.0% | +3.1% | |
| 2005 | $43.20 | $42.50 | 0.0% | -1.6% | |
| 2004 | $13.00 | $43.20 | 0.0% | +232.3% | |
| 2003 | $3.90 | $13.00 | 0.0% | +233.3% | |
| 2002 | $9.75 | $3.90 | 0.0% | -60.0% | |
| 2001 | $40.30 | $9.75 | 0.0% | -75.8% | |
| 2000 | $35.75 | $40.30 | 0.0% | +12.7% | |
| 1999 | $52.00 | $35.75 | 0.0% | -31.3% | |
| 1998 | $32.50 | $52.00 | 0.0% | +60.0% | |
| 1997 | $101.40 | $32.50 | 0.0% | -67.9% | |
| 1996 | $162.50 | $101.40 | 0.0% | -37.6% | |
| 1995 | $45.50 | $162.50 | 0.0% | +257.1% | |
| 1994 | $1,787.50 | $45.50 | 0.0% | -97.5% |
- Annualized
- -9.7%
- 1994–2026
- Average year
- +46.6%
- 32 full years
- Best year
- +410.7%
- 2019
- Worst year
- -97.5%
- 1994
- Positive years
- 13/32
- 41% up
Annualized (CAGR)
-9.7%
1994–2026
Average year
+46.6%
32 full years
Best year
+410.7%
2019
Worst year
-97.5%
1994
Positive years
13/32
41% up
Total return by period#
Annual
-400%-200%0%200%400%
1994-97%'94
1995+257%
1996-38%
1997-68%'97
1998+60%
1999-31%
2000+13%'00
2001-76%
2002-60%
2003+233%'03
2004+232%
2005-1.6%
2006+3.1%'06
2007-14%
2008-76%
2009-42%'09
2010+69%
2011-53%
2012-49%'12
2013+407%
2014-32%
2015-17%'15
2016-75%
2017+137%
2018+238%'18
2019+411%
2020+21%
2021-14%'21
2022-39%
2023-25%
2024-39%'24
2025+253%
2026-3.3%
Methodology#
Total returns, dividends reinvested, measured on ARWR. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Arrowhead Pharmaceuticals Inc.'s average annual return?
- Since 1994, Arrowhead Pharmaceuticals Inc. (ARWR) has returned about -9.7% a year (the compound annual growth rate) and an average calendar-year return of 46.6%.
- What were Arrowhead Pharmaceuticals Inc.'s best and worst years?
- Over 1994–2026, the best year was 2019 (+410.7%) and the worst was 1994 (-97.5%).
- How often is Arrowhead Pharmaceuticals Inc. up in a year?
- 13 of the 32 full years since 1994 were positive — about 41% of the time.
More on Arrowhead Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100